Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2012-10-31
2017-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some studies show that less than 50 % of the patients is satisfied by the care of the pain, whereas the criteria of evaluation of the RA improve under treatment. The chronic pain, is a complex and multifactorial subjective phenomenon requiring a multidimensional evaluation, while the current criteria of follow-up of the RA (DAS28, ACR criteria) investigate the pain in a single dimension that is the pain intensity.
So, the investigators do not arrange explanation for this observed dichotomy between the improvement of the clinical and biological inflammatory criteria of the RA and on the other hand the persistence of pain.
On the other hand, the interleukin (IL)-6, IL-17 and IL-33 are cytokines occurring in the physiopathology of RA and probably in the pain processing according to recent data of the literature.
The aim of this study is:
* to assess the multidimensional origin of the pain in RA patients by means of questionnaires
* to look for a possible correlation between the serum level of cytokines and pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases
NCT07167784
Chronic Pain in Rheumatoid Arthritis
NCT05038553
Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment
NCT02410304
Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis
NCT03005925
Efficiency of a Tight Monitoring by a Nurse Practitioner of Rheumatoid Arthritis (RA) Patients in Remission
NCT03027999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of providing written consent
Exclusion Criteria
* Fibromyalgia,
* A malignancy disease,
* An hemopathy,
* Psychiatric disorders or dementia and
* Acute infectious diseases and
* Receive or had received anti-IL6 therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascale Vergne-Salle, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Limoges
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Bordeaux- Pellegrin
Bordeaux, , France
CHU Gabriel Montpied
Clermont-Ferrand, , France
CHU Hôpital R. Salengro
Lille, , France
Service de Rhumatologie
Limoges, , France
CHU Hôtel-Dieu
Paris, , France
CHU Bois-Guillaume
Rouen, , France
CHU Hautepierre
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I11013/
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.